Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathway

Ashley M. VanCleave(Sanford Research), Jianning Tao(South Dakota State University)
Oncotarget
July 7, 2020
Cited by 7


Related Papers